Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy

被引：0
|
作者：
Bhavika K. Patel
Talal Hilal
Matthew Covington
Nan Zhang
Heidi E. Kosiorek
Marc Lobbes
Donald W. Northfelt
Barbara A. Pockaj
机构：
[1] Mayo Clinic,Department of Radiology
[2] Mayo Clinic,Department of Internal Medicine, Division of Hematology/Oncology
[3] Mayo Clinic,Department of Health Sciences Research, BioStatistics
[4] Maastricht University Medical Center,Department of Radiology
[5] Mayo Clinic,Department of Surgery
来源：
Annals of Surgical Oncology | 2018年 / 25卷
关键词：
Contrast-enhanced Spectral Mammography (CESM); Neoadjuvant Systemic Therapy (NST); Breast Cancer; Residual Malignancy; Underestimated Tumor Size;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1350 / 1356
页数：6
相关论文
共 50 条
  • [1] Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
    Patel, Bhavika K.
    Hilal, Talal
    Covington, Matthew
    Zhang, Nan
    Kosiorek, Heidi E.
    Lobbes, Marc
    Northfelt, Donald W.
    Pockaj, Barbara A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1350 - 1356
  • [2] ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy
    Talal Hilal
    Bhavika K. Patel
    [J]. Annals of Surgical Oncology, 2018, 25 : 652 - 653
  • [3] ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy
    Hilal, Talal
    Patel, Bhavika K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 652 - 653
  • [4] Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer
    Elkassas, Hebatalla
    El-Maadawy, Samar M.
    Saad, Sherihan Mahmoud
    Radwan, Amira H.
    Gareer, Sherihan W. Y.
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2022, 53 (01):
  • [5] Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer
    Hebatalla Elkassas
    Samar M. El-Maadawy
    Sherihan Mahmoud Saad
    Amira H. Radwan
    Sherihan W. Y. Gareer
    [J]. Egyptian Journal of Radiology and Nuclear Medicine, 53
  • [6] Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
    Steinhof-Radwanska, Katarzyna
    Grazynska, Anna
    Lorek, Andrzej
    Gisterek, Iwona
    Barczyk-Gutowska, Anna
    Bobola, Agnieszka
    Okas, Karolina
    Lelek, Zuzanna
    Morawska, Irmina
    Potoczny, Jakub
    Niemiec, Pawel
    Szyluk, Karol
    [J]. CURRENT ONCOLOGY, 2021, 28 (05) : 3448 - 3462
  • [7] Contrast-enhanced mammography and preoperative magnetic seed placement in breast cancer patients for the detection of residual disease following neoadjuvant systemic therapy
    Martinez, A. Mariscal
    Bravo, E. Iglesias
    Alva, H. Peris
    Martinez, P. Rodriguez
    Tomas, M. Luna
    Miguel, I. Pascual
    de Pablo, P. Puyalto
    [J]. RADIOLOGIA, 2024, 66 (05): : 419 - 430
  • [8] Breast Cancer Supplemental Screening: Contrast-Enhanced Mammography or Contrast-Enhanced MRI?
    Rashidi, Ali
    Lowry, Kathryn P.
    Sadigh, Gelareh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2024, 21 (04)
  • [9] Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
    Luczynska, Elzbieta
    Heinze-Paluchowska, Sylwia
    Hendrick, Edward
    Dyczek, Sonia
    Rys, Janusz
    Herman, Krzysztof
    Blecharz, Pawel
    Jakubowicz, Jerzy
    [J]. MEDICAL SCIENCE MONITOR, 2015, 21 : 1358 - 1367
  • [10] Accuracy of mammography, ultrasound, contrast-enhanced digital mammography, and MRI on the evaluation of residual in-breast disease after neoadjuvant endocrine therapy
    Zhang, Chi
    Kosiorek, Heidi
    Patel, Bhavika
    Ahmad, Sarwat
    Pockaj, Barbara
    Cronin, Patricia
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 44 - 46
12345